These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7677451)

  • 1. Treatment of refractory reflex sympathetic dystrophy with pamidronate.
    Maillefert JF; Chatard C; Owen S; Peere T; Tavernier C; Tebib J
    Ann Rheum Dis; 1995 Aug; 54(8):687. PubMed ID: 7677451
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonates for pain relief in reflex sympathetic dystrophy?
    Schott GD
    Lancet; 1997 Oct; 350(9085):1117. PubMed ID: 9343496
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphate excretion in reflex sympathetic dystrophy syndrome before and after a single infusion of pamidronate.
    Laroche M; Redon-Dumolard A; Moulinier L; Cantagrel A; Mazieres B
    Rev Rhum Engl Ed; 1997 Mar; 64(3):172-6. PubMed ID: 9090766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases.
    Kubalek I; Fain O; Paries J; Kettaneh A; Thomas M
    Rheumatology (Oxford); 2001 Dec; 40(12):1394-7. PubMed ID: 11752511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate.
    Cortet B; Flipo RM; Coquerelle P; Duquesnoy B; Delcambre B
    Clin Rheumatol; 1997 Jan; 16(1):51-6. PubMed ID: 9132326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates for RSDS and prostate cancer--more benefit then revealed!
    Barthel HR
    Joint Bone Spine; 2002 Oct; 69(5):521; author reply 522. PubMed ID: 12477242
    [No Abstract]   [Full Text] [Related]  

  • 7. Pooled results from 2 trials evaluating biphosphonates in reflex sympathetic dystrophy.
    Maillefert JF; Cortet B; Aho S
    J Rheumatol; 1999 Aug; 26(8):1856-7. PubMed ID: 10451097
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding.
    Siminoski K; Fitzgerald AA; Flesch G; Gross MS
    J Bone Miner Res; 2000 Oct; 15(10):2052-5. PubMed ID: 11028460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual energy X-ray absorptiometry in patients with lower limb reflex sympathetic dystrophy syndrome.
    Chapurlat RD; Duboeuf FP; Liens D; Meunier PJ
    J Rheumatol; 1996 Sep; 23(9):1557-9. PubMed ID: 8877925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pseudogout after pamidronate infusion.
    Wendling D; Tisserand G; Griffond V; Saccomani C; Toussirot E
    Clin Rheumatol; 2008 Sep; 27(9):1205-6. PubMed ID: 18500436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of pamidronate in complex regional pain syndrome type I.
    Robinson JN; Sandom J; Chapman PT
    Pain Med; 2004 Sep; 5(3):276-80. PubMed ID: 15367305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflex sympathetic dystrophy.
    Marshall AT; Crisp AJ
    Rheumatology (Oxford); 2000 Jul; 39(7):692-5. PubMed ID: 10908684
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of diphosphonate in Sudeck's disease: scintigraphic aspects].
    Vattimo A; Martini G; Pisani M
    Clin Ter; 1983 Jun; 105(6):493-7. PubMed ID: 6193923
    [No Abstract]   [Full Text] [Related]  

  • 14. [The association of algodystrophy and Lobstein's disease. Possible value of 3-amino-1-hydroxypropane-1,1-diphosphonic acid].
    Laroche M; Dromer C; Jacquemier JM; Mazières B; Arlet J
    Rev Rhum Mal Osteoartic; 1990 Mar; 57(3):221-2. PubMed ID: 2339269
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is the place of diphosphonates in the treatment of complex regional pain syndrome I?].
    Chauvineau V; Codine P; Hérisson C; Pellas F; Pélissier J
    Ann Readapt Med Phys; 2005 Apr; 48(3):150-7. PubMed ID: 15833263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates beyond their anti-osteoclastic properties.
    Varenna M
    Rheumatology (Oxford); 2014 Jun; 53(6):965-7. PubMed ID: 24273023
    [No Abstract]   [Full Text] [Related]  

  • 17. The successful use of pamidronate in an 11-year-old girl with complex regional pain syndrome: response to treatment demonstrated by serial peripheral quantitative computerised tomographic scans.
    Simm PJ; Briody J; McQuade M; Munns CF
    Bone; 2010 Apr; 46(4):885-8. PubMed ID: 19969114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pamidronate effect compared with a steroid on complex regional pain syndrome type I: Pilot randomised trial.
    Eun Young H; Hyeyun K; Sang Hee I
    Neth J Med; 2016 Jan; 74(1):30-5. PubMed ID: 26819359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of pamidronate in chronic and acute bone loss conditions.
    Devogelaer JP; Nagant de Deuxchaisnes C
    Medicina (B Aires); 1997; 57 Suppl 1():101-8. PubMed ID: 9567362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of reflex sympathetic dystrophy syndrome (complex regional pain syndrome type I).
    Berthelot JM
    Joint Bone Spine; 2006 Oct; 73(5):495-9. PubMed ID: 16837228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.